KPRX logo

Kiora Pharmaceuticals (KPRX) Company Overview

Profile

Full Name:

Kiora Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 13, 2015

Indexes:

Not included

Description:

Kiora Pharmaceuticals (KPRX) is a biotechnology company focused on developing innovative treatments for eye diseases. They aim to improve patient outcomes through advanced therapies, particularly for conditions like glaucoma and retinal diseases, using their proprietary drug delivery systems and formulations.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 12, 2021

Recent annual earnings:

Mar 25, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 11, 2024

Analyst ratings

Recent major analysts updates

Nov 12, 24 HC Wainwright & Co.
Buy
Aug 22, 24 HC Wainwright & Co.
Buy
Jul 23, 24 HC Wainwright & Co.
Buy
May 20, 24 HC Wainwright & Co.
Buy
Mar 27, 24 HC Wainwright & Co.
Buy
Feb 9, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
Nov 6, 23 HC Wainwright & Co.
Buy
Aug 24, 23 HC Wainwright & Co.
Buy
Aug 14, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Kiora Pharmaceuticals?
  • Does Kiora Pharmaceuticals pay dividends?
  • What sector is Kiora Pharmaceuticals in?
  • What industry is Kiora Pharmaceuticals in?
  • What country is Kiora Pharmaceuticals based in?
  • When did Kiora Pharmaceuticals go public?
  • Is Kiora Pharmaceuticals in the S&P 500?
  • Is Kiora Pharmaceuticals in the NASDAQ 100?
  • Is Kiora Pharmaceuticals in the Dow Jones?
  • When was Kiora Pharmaceuticals's last earnings report?
  • When does Kiora Pharmaceuticals report earnings?
  • Should I buy Kiora Pharmaceuticals stock now?

What is the ticker symbol for Kiora Pharmaceuticals?

The ticker symbol for Kiora Pharmaceuticals is NASDAQ:KPRX

Does Kiora Pharmaceuticals pay dividends?

No, Kiora Pharmaceuticals does not pay dividends

What sector is Kiora Pharmaceuticals in?

Kiora Pharmaceuticals is in the Healthcare sector

What industry is Kiora Pharmaceuticals in?

Kiora Pharmaceuticals is in the Biotechnology industry

What country is Kiora Pharmaceuticals based in?

Kiora Pharmaceuticals is headquartered in United States

When did Kiora Pharmaceuticals go public?

Kiora Pharmaceuticals's initial public offering (IPO) was on February 13, 2015

Is Kiora Pharmaceuticals in the S&P 500?

No, Kiora Pharmaceuticals is not included in the S&P 500 index

Is Kiora Pharmaceuticals in the NASDAQ 100?

No, Kiora Pharmaceuticals is not included in the NASDAQ 100 index

Is Kiora Pharmaceuticals in the Dow Jones?

No, Kiora Pharmaceuticals is not included in the Dow Jones index

When was Kiora Pharmaceuticals's last earnings report?

Kiora Pharmaceuticals's most recent earnings report was on May 12, 2021

When does Kiora Pharmaceuticals report earnings?

The date for Kiora Pharmaceuticals's next earnings report has not been announced yet

Should I buy Kiora Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions